With increasing interest in reducing the cost of oxygen therapy, we recently designed an oxygen-conserving cannula. It reduces the oxygen supply flow necessary to achieve adequate oxygen saturation, but because it requires the use of a reservoir situated under the nose, some patients find it obtrusive. We therefore designed a similar system but displaced the reservoir away from the face and onto the anterior chest wall where it could be hidden from view by the patient's clothing. We evaluated this pendant conserving nasal cannula (PNC) in seven hypoxemic patients with chronic obstrilctive pulmonary disease. We compared oxygen saturations achieved rising the PNC vs the standard t is now established that low flow oxygen therapy is I beneficial to hypoxemic patients with chronic obstructive pulmonary disease (COPD). The Nocturnal Oxygen Therapy Trial,' British,' and other stlldies7' have demonstrated that such low oxygen given between 12 and 24 h o~l r s daily improves survival. red~lces pulmonary hypertension, improves cor pulmonale, reduces polycythemia, improves psychomotor skills, and reduces depression. Oxygen is generally administered via a nasal cannula flowing c o n t i n~~o~~s l y throughout the respiratory cycle. However, the greatest benefit of oxygen therapy occllrs during early inspiration with much of the remaining oxygen lost to the surrounding environment.
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There has been some recent interest in improving the efficiency of oxygen delivery by a redesign of the oxygen cannula. We recently described an oxygenconserving nasal cannula with a storage reservoir over the mustache area of the face."'The goal of this device was to increase the proportion of oxygen flow d~lring d e sat~im-early inspiration and thereby achieve a d e q~~. t tioos with a reduction in total oxygen delivered. At flows o f 0 . 5 I,/min to the conserver cannula, the benefit was nearly that achieved at 2 IJmin using the steadv flow cannula. O n e diffic~ilty with prescribing oxygen is patient acceptance. While the conserver can reduce to one third to one half the present cost of oxygen, some patients found the reservoir over the mustache area *From the City of Hope X4edical Center. Duarte, CA. This work was made possible in part hy support from the James Roberts Research F11nd and by CHAD Theri~pe~~tics. Inc. IVooc/l land Hills, California. Man~~script received July 2: revision i~ccepted September .5. Rrprint rrqtrmts: Dr: Tip/,, Cit!l of Ilopr, 1.500 E n t Drrnrtr Rood.
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steady flow nasal cannula (SNC) at 0.5 through 4 Wmin. The mean improvement in oxygen saturation using the PNC vs the SNC was 3.3 percent at 0.5 Wmin, 4.3 percent at 1 L/min and 3.1 percent at 2 Wmin. These differences were statistically significant (p<0.001). The saturation achieved by the PNC at 0.5 Llmin was equivalent to that achieved by the SNC at 1.8 Llmin. We conclude that the PNC provides effective oxygen delivery to patients at supply flows substantially less than the SNC. The device is aesthetically acceptable to patients and its widespread use in patients requiring chronic oxygen therapy could bring about significant financial savings.
more obtrusive than standard cannt~las. In an effort to reduce the relative size ofthe cannula at the front ofthe face, we have redesigned the conserver cannula by displacing the storage reservoir off the face. In this design, the storage reservoir resides in a pendant which hangs below the neck on the anterior chest where it can be hidden under the clothing. In this st~ldy, we evaluated the efficacy of the pendant conserver c a n n~~l a by comparing it to the standard steady flow cannula at various oxygen supply flows using oxygen saturation meas~ired via ear oximetry. Figure 1 sho\vs the pendant consenter cannula. It consists of nasal prongs attached to t r~h~~l i~r c o n d~~i t Iei~ding to the oxygen reservoir. The oxvgen flo\vs to the jllnct~~re of the conduit and reservoir bag. The hag stores 40 mI, of gas and is available for oxygen enrichment. The tubing a150 provides some storage. Like the previor~sly described conserver cannr~las." the patient must do some nasal breathing during inspiration and expiration in order to derive added benefit from oxvgen stored in the reser\~oir. The pendant conserver stores oxygen during euhnlation; d~~r i n g early exhalation, the incre:lse in nasal pressure forces oxvgen into the reservoir. When the reservoir is filled, oxygen fills the c o n d~~i t (20 mL) leading to the ~xitirnt. Thr csffrct ic that oxygen enriched gns is poised For early inhalation.
Protocol
We recr~~ited seven patients with stable chronic lrlng disease with a mean age of55.6 2 14.6 years and a mean FEV, of0.72 2 4 L for this strldy. All s~~b j e c t s either had a resting ouygen satrlration of 90 percent or less or desatr~rated to less than 90 percent duringlow level exercise. They were allowed to continue their medications except they ror~ld not receive inhaled bronchodilators within one hour prior to the sttldy. Each s~~b j e r t gave informedconsent to participate in the st~ldy. Oxygen satl~ration was m e a s~~r e d by means ofan ear oximeter, FIGURE 1. The pendant oxygen conserving nasal cannrlla showing the nasal pmngs, storagetreflux conduit, and resewoir.
and oxygen flow was metered via a spimmetrically calibrated Gilmont mtometer accurate to 20.05 Umin. The study was performed with the subjects in a comfortable upright seated position. We measured oxygen saturations at mom air, 0.5, 1.0, 2.0, 3.0 and 4.0 Umin using the standard steady flow nasal cannula and at 0.5.l.Oand 2 Umin using the pendant conserver cannula. The order of presentation of cannulas was randomized. but all measurements started with lowest flow pmgressing to the highest flow. They were allowed to return to baseline by breathing room air between cannula changes. We determined the time required for saturation equilibration to occur and added two minutes to each oxygen flow level prior to recording saturation in an effort to assure that equilibration had taken place. We compared the mean saturations for each cannula at .5, 1. and 2 Umin using an analysis of variance. Table 1 summarizes the observed oxygen saturations achieved by each patient using the standard steady flow cannula and the pendant conserver cannula at various supply flows. The mean room air saturation was 8 8 . 4 + 2 . 8 p e r c e n t . T h e mean saturation at .5 Wmin was 90 + 2.9 percent for the standard cannula and 93.3 + 2.7 percent for the pendant conserver. At 1 Wmin, the mean saturation was 91 * 3.1 percent for the standard cannula and 95.3 + 2.4 percent for the pendant conserver. At 2 Wmin, the saturation was 9 3 . 7 a 1.3 percent for the standard cannula and 96.8 2 1.2 percent for the pendant conserver. These differences in oxygen saturations between the two cannulas were found to be statistically significant (pC0.001) by analysis of variance. Figure 2 compares the oxygen saturations achieved by using the standard cannula and pendant conserver for each subject at 0.5, 1.0, and 2 Wmin. The first point in each panel represents the standard cannula, and the second point represents the pendant conserver at each supply flow. In each instance, the pendant conserver yields a higher saturation compared to the steady flow cannula. Figure  3 represents the oxygen saturation performance curves for the standard steady flow cannula and the pendant conserver. At 0.5 Wmin, the benefit of supplemental oxygen via the pendant conserver is equivalent to that achieved from 1.85 Wmin using the standard steadyflow cannula. This provides a benefit ratio of 3.7:l. At 1 Wmin of oxygen delivered to the pendant conserver, the mean saturation is equivalent to the standard steady-flow cannula at 2.8 Wmin, yielding a benefit ratio of 2.8:l. At 2 Wmin flow to the pendant conserver cannula, the mean oxygen saturation is equivalknt to that of 4 Wmin for the standard steady flow cannula yielding a benefit ratio of 2:l.
We found that the pendant conserver achieved significantly better saturations than the standard steady flow cannula at the same supply flows (Fig 3) . The error stated by the manufacturer of the ear oximeter is ? 1.7 percent at saturations of 90 to 100 percent. Notwithstanding this range of error, this study is significant. These results are expected since exhalation occupies 60 to 70 percent of the respiratory cycle. In addition, during the last 30 to 40 percent of inhalation, gas flows principally to dead space. Therefore, gas exchange occurs primarily in the first 20 to 30 percent of the respiratory cycle. The pendant conserver stores a bolus of oxygen during exhalation making it available for early inspiration. In addition to this stored bolus, the pendant conserver operates as a steady flow cannula.
The goal of oxygen therapy is to prevent tissue hypoxia. The usual steady flow prescription is 2 Wmin with adjustments for sleep and exercise." If the pendant conserver cannula provides adequate saturations at lower supply flows, substantial financial savings could be achieved. This is particularly useful to patients requiring ambulatory oxygen.
Our previous studies described a similar benefit using a storage cannula with a reservoir residing in the mustache area of the face."' While both efficacy and comfort were improved, some patients found it obtrusive. Therefore, it became apparent that there would be some advantage to removing the reservoir from the face and hanging it around the neck like a pendant. The reservoir could then be hidden by clothing, thereby diminishing its obtrusiveness while retaining the value of its storage capabilities. Subjects were asked to comment about the comfort and appearance of the pendant conserver. Most subjects report that the pendant conserver is more comfortable than the standard steady flow cannula and felt it to be less obtrusive than the presently marketed mustache conserver. Both the pendant and mustache conservers could diminish the obtrusiveness of the oxygen cannister by reducing the storage requirement, thus making smaller and lighter oxygen containers more feasible.
In conclusion, the pendant oxygen conserving cannula provides effective oxygen delivery at substantially reduced oxygen supply flows as compared to the standard steady flow cannula. Because of this improved efficacy, the pendant conserver could significantly reduce the cost of oxygen therapy. It is more comfortable than the standard steady flow cannula. Furthermore, the fact that the reservoir is hidden from view makes the system aesthetically more acceptable than the mustache configured conserver. 
